1. Erratum Erratum to: Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis. (10th March 2021) Authors: Simmons, Bryony; Wentzel, Hannah; Mobarak, Sara; Eslami, Gholamali; Sadeghi, Anahita; Ali Asgari, Ali; Abbaspour Kasgari, Hamideh; Tirgar Fakheri, Hafez; Merat, Shahin; Hill, Andrew Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 6(2021) Page Start: 1653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erratum to: Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis. (10th March 2021) Authors: Simmons, Bryony; Wentzel, Hannah; Mobarak, Sara; Eslami, Gholamali; Sadeghi, Anahita; Ali Asgari, Ali; Abbaspour Kasgari, Hamideh; Tirgar Fakheri, Hafez; Merat, Shahin; Hill, Andrew Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 6(2021) Page Start: 1653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER). (28th November 2021) Authors: Mobarak, Sara; Salasi, Mehdi; Hormati, Ahmad; Khodadadi, Javad; Ziaee, Masood; Abedi, Farshid; Ebrahimzadeh, Azadeh; Azarkar, Zohreh; Mansour-Ghanaei, Fariborz; Joukar, Farahnaz; Yeganeh, Sara; Yaghubi Kalurazi, Tofigh; Naghipour, Mohammadreza; Mehrabi, Zeinab; Bahadori, Amir Reza; Yaghoubi, Shoe... Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 3(2022) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Issue 4 (April 2021) Authors: Poustchi, Hossein; Darvishian, Maryam; Mohammadi, Zahra; Shayanrad, Amaneh; Delavari, Alireza; Bahadorimonfared, Ayad; Eslami, Saeid; Javanmard, Shaghayegh Haghjooy; Shakiba, Ebrahim; Somi, Mohammad Hossein; Emami, Amir; Saki, Nader; Hormati, Ahmad; Ansari-Moghaddam, Alireza; Saeedi, Majid; Ghase... Journal: Lancet infectious diseases Issue: Volume 21:Issue 4(2021) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial. (19th August 2020) Authors: Sadeghi, Anahita; Ali Asgari, Ali; Norouzi, Alireza; Kheiri, Zahedin; Anushirvani, Amir; Montazeri, Mahnaz; Hosamirudsai, Hadiseh; Afhami, Shirin; Akbarpour, Elham; Aliannejad, Rasoul; Radmard, Amir Reza; Davarpanah, Amir H; Levi, Jacob; Wentzel, Hannah; Qavi, Ambar; Garratt, Anna; Simmons, Bryon... Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 11(2020) Page Start: 3379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis. (16th October 2020) Authors: Simmons, Bryony; Wentzel, Hannah; Mobarak, Sara; Eslami, Gholamali; Sadeghi, Anahita; Ali Asgari, Ali; Abbaspour Kasgari, Hamideh; Tirgar Fakheri, Hafez; Merat, Shahin; Hill, Andrew Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 2(2021) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗